Candida auris and Nosocomial Infection

Area of Science:

• Medical Mycology
• Infectious Diseases
• Genomics

Background:

• Candida auris, identified in 2009, is a multidrug-resistant (MDR) fungal pathogen.
• It causes nosocomial infections, particularly in immunocompromised individuals, leading to candidemia with high mortality rates.
• This pathogen poses a significant global health threat due to its increasing prevalence and resistance patterns.

Purpose of the Study:

• To review the prevalence, biology, drug resistance, virulence factors, and management of Candida auris infections.
• To highlight the challenges in accurate identification and treatment of Candida auris.
• To emphasize the importance of preventive control measures against Candida auris transmission.

Main Methods:

• Review of existing literature on Candida auris.
• Analysis of whole genome sequence (WGS) data to understand phylogeographic distribution.
• Discussion of diagnostic inconsistencies and their impact on treatment.

Main Results:

• Whole genome sequencing reveals distinct phylogeographic genotypes of Candida auris, suggesting geographical specialization and spread.
• Candida auris frequently exhibits multidrug resistance and unusual antifungal susceptibility profiles.
• Commercial identification methods often yield inconsistent results, leading to misidentification and treatment failures.

Conclusions:

• Candida auris is a growing global health concern requiring urgent attention.
• Effective management necessitates accurate diagnostics, understanding of resistance mechanisms, and robust infection control strategies.
• Preventive measures are paramount to interrupt the transmission of this resilient pathogen.